Treace Medical Concepts, Inc. (TMCI) Operating margin 2019–2025
Treace Medical Concepts, Inc. (TMCI) operating margin by fiscal year — reported operating income divided by reported revenue.
-25.5%FY2025 · since FY2019: -9.0% → -25.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -25.5% | +1.1 pp |
| FY2024 | -26.6% | +0.9 pp |
| FY2023 | -27.5% | -2.9 pp |
| FY2022 | -24.6% | -7.1 pp |
| FY2021 | -17.5% | -19.0 pp |
| FY2020 | 1.5% | +10.5 pp |
| FY2019 | -9.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TMCI financial trends
TMCI RevenueTMCI Net incomeTMCI Net marginTMCI Gross profitTMCI Gross marginTMCI Operating incomeTMCI Operating cash flowTMCI Free cash flowTMCI Capital expendituresTMCI Return on equityTMCI Stock buybacksTMCI Dividends paidTMCI Total assetsTMCI Total liabilitiesTMCI Shareholders’ equityTMCI overview →